FDA Says No Decision Reached Yet On Oxybenzone/Octinoxate Ban Petition
This article was originally published in The Rose Sheet
According to industry, available scientific evidence regarding oxybenzone’s and octinoxate’s effects on coral does not support their removal from the OTC sunscreen drug monograph’s list of permitted UV filters, and FDA is fully compliant with federal environmental laws, contrary to the Center for Biological Diversity’s suggestions. FDA says the petition raises complex issues requiring extensive review.
You may also be interested in...
OTC Sunscreen Ingredients’ Environmental Impacts Likely To Be Growing Discussion, Including At US FDA
Designating new “critical habitats” off US shores, as proposed by the National Marine Fisheries Service, would require federal agencies “to ensure that actions they plan to undertake, fund, or authorize do not destroy or adversely modify that habitat.” That could factor in the US FDA’s OTC sunscreen review program and potential follow-up on a 2018 citizen petition calling for a ban on "coral-killing" UV filters.
2018 In Review: California, Hawaii Pass Personal-Care Legislation Among 300+ State Bills Overall
On par with 2017, the Personal Care Products Council was tracking more than 300 state bills last year with potential implications for its members, including measures ultimately enacted by California and Hawaii to deter cosmetic animal testing and ban environmentally questionable sunscreens.
Key West Weighing Oxybenzone/Octinoxate Sunscreen Ban Per Hawaii’s Example
The Florida island city could be the next jurisdiction to prohibit the sale of oxybenzone- and octinoxate-containing sunscreens. Industry maintains that available science does not clearly link the ingredients to coral decline, with the Personal Care Products Council asking to present before the Key West City Commission at its January meeting.